Skip to main content

Peripheral Neuropathy News

Related terms: Neuropathy

Exercise May Prevent the Nerve Damage That Comes With Chemotherapy

TUESDAY, July 2, 2024 – Simple exercises performed during rounds of chemotherapy can help people avoid nerve damage normally associated with the cancer-killing drugs, a new study suggests. About...

ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy

FRIDAY, June 7, 2024 – Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel (every three weeks)...

Distal Symmetric Polyneuropathy Often Undiagnosed

WEDNESDAY, May 8, 2024 – Distal symmetric polyneuropathy (DSP) is common and is frequently undiagnosed, according to a study published online May 8 in Neurology. Melissa A. Elafros, M.D., Ph.D.,...

Vitamin D Insufficiency Linked to Paclitaxel-Induced Neuropathy

WEDNESDAY, Nov. 8, 2023 – Pretreatment vitamin D insufficiency is associated with an increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy (CIPN) from paclitaxel, according to a ...

Aerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms

WEDNESDAY, Aug. 2, 2023 – A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer,...

FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review

NEW YORK--(BUSINESS WIRE)--Jun 21, 2012 - Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the use of Lyrica (pregabalin) capsules CV for the management of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

gabapentin, duloxetine, pregabalin